scholarly journals Long-term neurodevelopmental outcomes of infants born late preterm: a systematic review

2015 ◽  
pp. 91 ◽  
Author(s):  
Stacey Dusing ◽  
Tanya Tripathi
Keyword(s):  
Systematic Review ◽  
Late Preterm ◽  
Neurodevelopmental Outcomes

scholarly journals Long-term Neurodevelopmental Outcomes after Moderate and Late Preterm Birth: A Systematic Review

2021 ◽  
Author(s):  
Lexuri Fernández de Gamarra-Oca ◽  
Natalia Ojeda ◽  
Ainara Gómez-Gastiasoro ◽  
Javier Peña ◽  
Naroa Ibarretxe-Bilbao ◽  
...  
Keyword(s):  
Systematic Review ◽  
Preterm Birth ◽  
Late Preterm ◽  
Neurodevelopmental Outcomes ◽  
Late Preterm Birth

Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births

2021 ◽  
pp. fetalneonatal-2021-322152
Author(s):  
Amir Aviram ◽  
Kellie Murphy ◽  
Sarah McDonald ◽  
Elizabeth Asztalos ◽  
Arthur Zaltz ◽  
...  
Keyword(s):  
Birth Weight ◽  
Neonatal Resuscitation ◽  
Late Preterm ◽  
Preterm Neonates ◽  
Neurocognitive Disorder ◽  
Antenatal Corticosteroids ◽  
Neurodevelopmental Outcomes ◽  
Increased Risk ◽  
Visual Testing

ObjectivesAntenatal corticosteroids (ACS) decrease neonatal mortality and morbidity among preterm neonates, yet there has been concern regarding their long-term safety. We hypothesised that potential long-term adverse effects of ACS may be observed among infants born during the late preterm period (LPT, 340/7–366/7 weeks of gestation), when the benefits of ACS are subtle.DesignPopulation-based, retrospective cohort.SettingOntario, Canada, between 2006 and 2011.PatientsAll live singleton infants born during the LPT period with a minimum 5-year follow-up.InterventionsExposure to ACS prior to 340/7 weeks of gestation.Main outcome measuresSuspected neurocognitive disorder, audiometry testing or visual testing.ResultsOverall, 25 668 infants were eligible for analysis, of whom 2689 (10.5%) received ACS. Infants in the ACS group had lower mean birth weight and higher rates of birth weight <10th percentile, neonatal resuscitation and neonatal intensive care unit admission. At 5 years of age, ACS exposure was associated with an increased risk of suspected neurocognitive disorder (adjusted HR (aHR) 1.12, 95% CI 1.05 to 1.20), audiometry testing (aHR 1.20, 95% CI 1.10 to 1.31) and visual testing (aHR 1.06, 95% CI 1.01 to 1.11).ConclusionIn children born during the LPT period, exposure to ACS prior to 340/7 weeks of gestation is associated with an increased utilisation of the healthcare system related to audiometry and visual testing and suspected neurocognitive disorders by 5 years of age.

scholarly journals Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review

The Lancet ◽  
2012 ◽  
Vol 379 (9814) ◽  
pp. 445-452 ◽  
Author(s):  
Michael K Mwaniki ◽  
Maurine Atieno ◽  
Joy E Lawn ◽  
Charles RJC Newton
Keyword(s):  
Systematic Review ◽  
Neurodevelopmental Outcomes

696: Long-term neurodevelopmental outcomes of late preterm and early term neonates

2014 ◽  
Vol 210 (1) ◽  
pp. S342-S343 ◽  
Author(s):  
Cynthia Gyamfi-Bannerman ◽  
Moeun Son ◽  
Cande Ananth
Keyword(s):  
Late Preterm ◽  
Neurodevelopmental Outcomes ◽  
Term Neonates ◽  
Early Term

scholarly journals Protocol for a systematic review and meta-analysis of long-term neurocognitive outcomes in paediatric traumatic brain injury

BMJ Open ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. e035513
Author(s):  
Dawn Shu Hui Looi ◽  
Mark Sen Liang Goh ◽  
Sharon Si Min Goh ◽  
Jia Ling Goh ◽  
Rehena Sultana ◽  
...  
Keyword(s):  
Systematic Review ◽  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Systematic Reviews ◽  
Meta Analysis ◽  
Small Sample ◽  
Neurodevelopmental Outcomes ◽  
Neurocognitive Outcomes ◽  
Meta Analyses

IntroductionChildren who suffer from traumatic brain injury (TBI) are at risk of permanent brain damage and developmental deficits. Reports on neurodevelopmental outcomes in paediatric TBI suffer from small sample size and varying outcome definitions in the neurocognitive domains tested. This protocol describes a systematic review and meta-analysis of paediatric TBI in the following key neurocognitive domains: executive function, perceptual–motor function, language, learning and memory, social cognition and complex attention.MethodsA comprehensive search comprising studies from Medline, Cochrane, Embase and PsycINFO published from 1988 to 2019 will be conducted. We will include studies on children ≤18 years old who suffer from mild, moderate and severe TBI as determined by the Glasgow Coma Scale that report neurocognitive outcomes in domains predetermined by the Diagnostic and Statistical Manual of Mental Disorders fifth edition criteria. Systematic reviews, meta-analyses, randomised controlled trials, case–control, cohort and cross-sectional studies will be included. References from systematic reviews and meta-analyses will be hand-searched for relevant articles. A meta-analysis will be performed and effect sizes will be calculated to summarise the magnitude of change in each neurocognitive domain compared at different timepoints and stratified by severity of TBI. Included studies will be pooled using pooled standardised mean differences with a random effects model to determine an overall effect. In the scenario that we are unable to pool the studies, we will perform a narrative analysis.Ethics and disseminationEthics approval is not required for this study.The authors of this study will publish and present the findings in a peer-reviewed journal as well as national and international conferences. The results of this study will provide understanding into the association between different severities of paediatric TBI and long-term neurocognitive outcomes.PROSPERO registration numberCRD42020152680.

scholarly journals Global prevalence of long-term neurodevelopmental impairment following extremely preterm birth: a systematic literature review

2021 ◽  
Vol 49 (7) ◽  
pp. 030006052110280
Author(s):  
Sujata P. Sarda ◽  
Grammati Sarri ◽  
Csaba Siffel
Keyword(s):  
Systematic Review ◽  
North America ◽  
Major Complication ◽  
Neurodevelopmental Outcomes ◽  
Extreme Prematurity ◽  
Extremely Preterm ◽  
Extremely Preterm Infants ◽  
Neurodevelopmental Impairment ◽  
Extremely Preterm Birth

Objective Neurodevelopmental impairment (NDI) is a major complication of extreme prematurity. This systematic review was conducted to summarize the worldwide long-term prevalence of NDI associated with extreme prematurity. Methods Embase and MEDLINE databases were searched for epidemiologic and observational/real-world studies, published in English between 2011 and 2016, reporting long-term prevalence of NDI (occurring from 1 year) among extremely preterm infants born at gestational age (GA) ≤28 weeks. Results Of 2406 articles identified through searches, 69 met the protocol NDI definition (24 North America, 25 Europe, 20 Rest of World). Prevalence of any severity NDI in North America was 8%–59% at 18 months to 2 years, and 11%–37% at 2–5 years; prevalence of moderate NDI in Europe was 10%–13% at 18 months to 2 years, 3% at 2–5 years, and 9%–19% at ≥5 years; prevalence of any NDI in Rest of World was 15%–61% at 18 months to 2 years, and 42% at 2–5 years (no North America/Rest of World studies reported any NDI at ≥5 years). A trend toward higher prevalence of NDI with lower GA at birth was observed. Conclusions Extreme prematurity has a significant long-term worldwide impact on neurodevelopmental outcomes.

scholarly journals Antenatal corticosteroids for impending late preterm (34-36+6 weeks) deliveries—A systematic review and meta-analysis of RCTs

PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0248774
Author(s):  
Mangesh Deshmukh ◽  
Sanjay Patole
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Neonatal Resuscitation ◽  
Late Preterm ◽  
Respiratory Support ◽  
Preterm Neonates ◽  
Antenatal Corticosteroids ◽  
Neurodevelopmental Outcomes ◽  
Level Of Evidence

Background Administration of antenatal corticosteroids (ANC) for impending preterm delivery beyond 34 weeks of gestation continues to be a controversial issue despite various guidelines for obstetricians and gynaecologists. Objective To compare outcomes following exposure to ANC for infants born between 34–36+6 weeks’ gestation. Methods A systematic review of randomised controlled trials (RCT) reporting neonatal outcomes after ANC exposure between 34–36+6 weeks’ gestation using Cochrane methodology. Databases including PubMed, Embase, Emcare, Cochrane Central library and Google Scholar were searched in May 2020. Primary outcomes: (1) Need for respiratory support (Mechanical ventilation, CPAP, high flow) or oxygen (2) Hypoglycemia. Secondary outcomes included respiratory distress syndrome (RDS), transient tachypnoea of newborn (TTN), need for neonatal resuscitation at birth [only in the delivery room immediately after birth (not in neonatal intensive care unit (NICU)], admission to NICU, mortality and developmental follow up. Level of evidence (LOE) was summarised by GRADE guidelines. Main results Seven RCTs (N = 4144) with low to high risk of bias were included. Only one RCT was from high income countries, Meta-analysis (random-effects model) showed (1) reduced need for respiratory support [5 RCTs (N = 3844); RR = 0.68 (0.47–0.98), p = 0.04; I2 = 55%; LOE: Moderate] and (2) higher risk of neonatal hypoglycaemia [4 RCTs (N = 3604); RR = 1.61(1.38–1.87), p<0.00001; I2 = 0%; LOE: High] after ANC exposure. Neonates exposed to ANC had reduced need for resuscitation at birth. The incidence of RDS, TTN and surfactant therapy did not differ significantly. None of the included studies reported long-term developmental follow up. Conclusions Moderate quality evidence indicates that ANC exposure reduced need for respiratory support, and increased the risk of hypoglycaemia in late preterm neonates. Large definitive trials with adequate follow up for neurodevelopmental outcomes are required to assess benefits and risks of ANC in this population.

Steroid Use for Established Bronchopulmonary Dysplasia: Study Protocol for a Systematic Review and Meta-analysis.

2021 ◽  
Author(s):  
Sabina Strashun ◽  
Joanna Seliga-Siwecka ◽  
Roberto Chioma ◽  
Alessandra Rossi ◽  
Kinga Zielińska ◽  
...  
Keyword(s):  
Systematic Review ◽  
Preterm Infants ◽  
Bronchopulmonary Dysplasia ◽  
Therapeutic Option ◽  
Meta Analysis ◽  
Grey Literature ◽  
Steroid Treatment ◽  
Brain Maturation ◽  
Neurodevelopmental Outcomes

Abstract BackgroundBronchopulmonary dysplasia (BPD) is a serious chronic respiratory condition that affects approximately 60% of preterm infants born before 27 weeks’ gestation, and leads to both, short and long-term pulmonary and non-pulmonary complications. Infants suffering from BPD are difficult to wean off of respiratory support, delaying feeding advancement and hospital discharge. Postnatal steroids during the first three weeks of life have been demonstrated to be effective in decreasing the incidence of BPD, however concerns in relation to neurodevelopmental outcomes are reported as well. On the contrary, data regarding the use of late postnatal steroids, once BPD is established are sparse and inconsistent. Here, we report a protocol for a systematic review, which aims to determine the efficacy and long-term safety of post-natal steroids for the treatment of established BPD in preterm infants.MethodsMEDLINE, Embase, Cochrane databases and sources of grey literature will be searched with no time or language restriction for studies that evaluated the use of postnatal steroids for preterm infants with established BPD. Odds ratios and 95% confidence intervals will be determined and pooled using a random effects model. For the studies that cannot be combined in the meta-analysis, a narrative synthesis of the results will be provided. DiscussionThe use of steroids as a therapeutic option for established BPD, after reaching the critical phase of the disease, is limited by the concern of possible neurological side effects that were documented for the preventive use of this medication. However, steroid treatment for established BPD may be administered in an attempt to reduce length of stay and home oxygen therapy, which are both associated with high levels of parental stress and healthcare costs. Moreover, a late timing for steroid treatment may show a more favourable safety profile in terms of neurodevelopment outcomes, considering the added postnatal brain maturation of these infants. As BPD is one of the neonatal complications that lack an effective course-modifying treatment approach to-date, the proposed systematic review offers considerable clinical relevance.Systematic review registration The protocol is registered in the PROSPERO register (registration number CRD42021218881).

Sign in / Sign up

Export Citation Format

Share Document